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Summary.-Transplantation of a Moloney sarcoma-virus (MSV-M)-transformed
producer cell line (Sac(+)) induced progressively or regressively growing tumours
in mice. Progressive growth always occurred after transplantation of an MSV-M
non-producer transformant (Sac(-)), whereas the MSV-M released from the pro-
ducer cells (Sac virus) always induced tumours which regressed.
In contrast to the non-producer, the producer transformant Sac(+) as well as Sac
virus induced a strong immune response, detected in vitro by cell- and antibody-
mediated cytotoxicity assays, and in vivo by transplantation immunity.
Implantation of Sac(-) cells led to solid, under-vascularized tumours, consisting
histologically of uniform densely packed tumour cells. Sac-virus-induced tumours,
however, were very well vascularized and arose by proliferation of different connec-
tive-tissue cells. Aftertransplantation of Sac(+) cells, tumours were found to consist
of typical tumour cells morphologically similar to Sac(-) cells intermingled with
proliferated connective-tissue cells.
Cultivation of tumour fragments from Sac(+) and Sac(-) tumours was followed
by outgrowth of transformed tumour cells with the properties of the originally implanted cells. Tumour explant cultures from Sac-virus-induced tumours did not
lead to growth of stably transformed cells.
Co-culture of mouse embryo fibroblasts (MEF) with Sac(+) cells resulted in over-
growth of the transformed cells. Infection of MEF with Sac virus led to transiently transformed cells.
It is concluded that Sac(+) cell tumours will resist the strong immune defence
mechanisms they induce and grow progressively, if the inoculated cells are able to
build up a solid, poorly vascularized nodule in the tissue. This always happens after
implantation of 106 cells, but only occasionally when fewer cells are inoculated.
Sac-virus-induced tumours will always regress owing to the strong immune res-
ponse. Theregression isfurtheredbythe factthat MSV-M infectionrarelyif everleads
to a stable transformation.
EXTENSIVE STUDlES on the mechanism genicity of murine sarcoma virus (MSV) of regression of tumours induced in mice may be the reason that regression occurs
by murine Moloney sarcoma virus in MSV-induced local tumours (Herber- (MSV-M) (Levy & Leclerc, 1977) were man, 1977). mainly (if not exclusively) focused on There is no doubt that regression of
immunological parameters accompanying MSV-M-induced tumours is the conse-
tumour development and regression. Re- quence of a sequence of immunological sults ofthese studies led to the assumption events during tumour development. In
that the particularly strong immuno- immunoincompetent tumour-bearers there
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is no regression (Fefer et al., 1967; Law et
al.,1968; Collavo et al., 1976; Stutman,
1975; Davis, 1975); tumours grow pro-
gressively and lead to the death of their
hosts.
Transformation by the usually used
original strain of MSV-M obviously does
not lead to cells with the capacity for sus-
tained division (Bather et al., 1968). This
peculiarity has to our knowledge not been
considered as an additional prerequisite to
a strong immune response for the regu-
larly regressive course of MSV-M-induced
tumours.
The aim of the present study was to
emphasize the probable importance of the
manner in which the tumour evolved for
the outcome of the development of an
antigenic tumour in an immunocompetent
host. It is suggested that, in contrast to
evocation from continuous recruitment of
normal contiguous cells by a new viral
infection, a tumour that evolves by pro-
liferation oftransformed autonomous cells
has a chance to growprogressively in spite
of a strong immune response.
MATERIALS AND METHODS
Animals.-STU inbred mice were as de-
scribed in previous studies (Weiland &
Weiland, 1974; Weiland & Mussgay, 1975,
1976). STU mouse embryo fibroblasts (STU-
MEF) were establislied from 17-day-old
embryos.
Virus and cells.-The Moloney isolate of
MSV(MSV-M) was as used inprevious studies
(Weiland & Weiland, 1974; Weiland et al.,
1978). It was obtained from Flow Labora-
tories Inc. (Rockville, Md.), Code No. MSV-
B-62. The origin of the non-producer cell
"Sac(-)" from a secondary tumour that
developed at the site where a primary MSV-
M-induced tumour had regressed was de-
cribed recently (Weiland et al., 1978). Rescue
of sarcoma virus (Sac virus) by Moloney
helper virus (MLV-M) produced by the cell
line "Be" led to the sarcoma- and helper-
virus-producing cell "Sac(+)" (Weiland etal.,
1978). The cell lines were cultured in Eagle's
minimum essential medium (MEM) with 10%
foetal calf serum (FCS) and antibiotics. The
Sac cells are, according to Weil (1978), stable
transformants as judged by their ability to
form colonies in semi-solid agar.
VirU8 a88ay8.-Focus and XC-plaque
assays were performed by the usual pro-
cedure (Ting & Bader, 1969; Rowe et al.,
1970).
Tumour induction. Graded doses of
tumour cells (Sac(-) and Sac(+)) in phos-
phate-buffered saline (PBS) were injected
i.m. in a volume of 0-1 ml into the thigh
region of 6-week-old mice of both sexes. In
addition, tumour induction was investigated
after treatment ofSac(+) cells bymitomycin
C (Boehringer, Mannheim, Germany) for
proliferation inhibition (100 jig mitomycin
C/107 cells, 30 min, 37T). Sac(+) culture
supernatant was diluted 1:2 with PBS or
PBS containing 4 jig/ml Polybren (EGA-
Chemie, Steinheim/Albuch, Germany) before
i.m. injection of 0-1 ml containing 104 fOCUS_
forming units (FFU) and 106 XC plaque-
inducing units. Sac virus was also concen-
trated 400-fold by ultracentrifugation before
i.m. injection. After cell or virus injection,
tumour development was followed 3 times a
week for at least 6 weeks.
Hi8tOlOgical and ultrahi8tological 8tudie8.-
Forhistopathological studies, fragments from
the tumours were fixed by immersion in 10%
neutral formaldehyde. The fixed tissue was
then dehydrated, embedded in paraffin, sec-
tioned at 6 pm, and stained with haematoxy-
lin and eosin, PAS or Masson's trichrome
stain.
Specimens for electron microscopy were
removed from the tumours and immediately
fixed in 2-5% glutaraldehyde buffered with
0-Im sodium caeodylate atpH 7-2. Afterpost-
fixation in I% osmium tetroxide the speci-
mens were dehydrated and embedded in
Araldite. Thin sections were stained with
uranyl acetate and lead citrate and examined
in a Siemens electron microscope 101,
operating at 80 kV.
Cultivation procedurefor tumourfragment8.
-Twelvedays after tumour induction, about
5-7 small tumour fragments obtained by
mechanical dissociation with scissors were
placed on plastic Petri dishes 60 mm in
diameter. A few minutes later the loosely
attached fragments were overlaid with MEM
+10% FCS+antibioties, avoiding detach-
ment ofthefragments from the bottom ofthe
culture dishes. After incubation for 9 days in
a humid 5% C02 atmosphere, outgrown cells934 F. WEILAND, E. WEILAND AND M. MUSSGAY
weresubcultured, carebeing taken not to lose
anycells.Depending onthegrowthbehaviour,
further subcultures were prepared.
As,sayfor growth in soft agar.-To achieve
efficient colony growth in soft agar, the pre-
sence ofSTU-MEF was necessary. STU-MEF
were used as UV-irradiated 1-day-old mono-
layers of about 106 seeded cells beneath the
base agar in 60mm plastic Petri dishes, or
suspended in the soft agar overlay containing
5 x 105 viable STU-MEF per dish.
Assay for cell- and antibody-mediated cyto-
toxicity (CMC, AMC) and transplantation
protection.-As described in detail in a former
study (Weiland et al., 1978), a 3H-proline
microcytotoxicity assay (HPMA) was used
for demonstration of CMC and AMC. The
helper-virus-producing cell line Bc served as
the target cell for CMC, since this proved to
be highly sensitive for cytotoxic effector cells
in contrast to Sac(+) cells, although both
cells possess common surface antigens. For
the demonstration of complement (C')-
dependent cytotoxic antibodies, both pro-
ducer cells (Bc and Sac(+)) proved to be very
sensitive (Weiland et al., 1978). Transplanta-
tion protection against Sac(+) cells was
studied 13 days after Sac virus injection.
Infection of STU-MEF with Sac virus and
co-cultivation o STU-MEF with transformed
Sac virus-producing cells.-One day after
plating of 3-2 x106 secondary STU-MEF in
Falcon-75 culture flasks, the supernatant was
removed and 1-6 ml containing either 150
Sac(+) cells or 8 x104 FFU of Sac virus
derived from Sac(+) cell-culture supernatant
were added. For comparison, material from
homogenates oftumours inducedbyinjection
of MSV-B-62 also containing 8 x104 FFU
was used. One culture was mock-infected with
1-6 ml MEM+FCS+antibiotics. After an
incubation period of 90 min at 37T, 20 ml
MEM+10% FCS+antibiotics were added.
Six days later the supernatant was harvested
and stored at -80'C until investigation for
FFU and XCplaque-inducing virus. The cells
per culture were counted. Portions of the
cells wereplatedagain in Falcon-75 flasks and
also in 60mm dishes (for morphological studies). A-nother portion was investigated for colony-forming ability in soft agar
(2-3 x 105 cells per dish) and a further por-
tion was transplanted i.m. into 6-week-old
mice (2 x 105 cells/mouse) for tumour-induc-
tion studies. This procedure was repeated 3
times at intervals of one week.
RESULTS
Cour8eoftumourdevelopment
Induction of tumour development by
Sac virus was detectable between 6 and 8
days after i.m. injection. Leg enlargement
was demonstrable for 1-2 weeks, reaching
a maximum size about 9-13 days after
virus injection. Regression of the tumours
occurred in all cases and was complete at
the latest 29 days after infection. Presence
ofPolybren (Pb) (2 tig/ml final concentra-
tion) used in virus assays to enhance
sarcoma-virus infectivity (Toyoshima &
Vogt, 1969) increased the tumour inci-
dence and induced a greater leg enlarge-
ment. In the presence of Pb, 18/19 in-
fected micedeveloped tumours in contrast
to the 13/18 animals infected in the
absence of Pb. Sac virus, concentrated
400-fold before injection, also induced
tumours (14/19 mice), which always re-
gressed.
Tumourdevelopment aftertransplanta-
tion of transformed cells is shown in the
upper part of Table 1. Tumour incidence,
latentperiod betweentransplantation and
TABLEI.-Tumour cour8e induced by non-
producer (Sac(-)) ce118 and producer
(Sac(+)) CeI18
Mice with tumours/total
mice (latent period
in days) tumour fatet
qo. of
,)rans-
is
t
PI[anted
k
cells Sac Sac
106 n.t. 12/12 (> 7)
12 P
105 4/4 (> 8) 11/11 (> 7)
4 P 9P; 2 R
104 5/5 (> 8-12) 11/12 (7-8)
5 p 5 P; 6 R
103 2/6 (15, 23) 11/12 (7-9)
2 P I P; IOR
102 0/6 5/12 (8)
1 P; 4R
101 0/6 3/12 (8)
3 R
106 12/12 (4) 24/24 (4)
12 P 24 P
105 12/12 24/24 (4-10)
12 P 18 P; 6 R
104 12/12 (4-14) 23/23 (4-10)
12 P 13 P; 10 R
Tumour cells
continuously
maintained
in vitro
Tumour cells
re-isolated
from 12-day-
old tumours
t P: progressive; R: regressive.
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evidetice f'oi- ttimo-Lirs, and tumour fate
(ultimate progressive or i-egressive course)
are shown in detail. Sac(-)-cell-indueed
tumotirs were demonstrable 8-23 days
after transplantation and always grew
progressively. Sac(+)-cell-induced tum-
ours were seen 7-9 days after transplaiita-
tion; in most cases cell concentration used
for transplantation influenced t,umour
course, i.e. the ratio of progressively to
regressively growing tiumours. Application
of mitomycin C-inhibited Sac(+) cells
at a concentration of 106 cells/mouse led
to tumour development in all 17 treated
mice 6-8 days after cell transplantation.
These tumours showed the same growth
course as Sac virus-indticed tumours, and
always regressed.
Morpholoyy of tunioui-s
Sac-virus-induced tutiiours developed
at the site of inoculation to a maximal
diameter of I-0 cm or less. Tumour masses
were rather soft on palpation, and homo-
geneous. Sometimes, however, they de-
veloped a nodular appearance before re-
gression occurred. The cut surface was
reddish grey. Tissue in the perimeter of
the tumours had a remai-kable oedematous
appearance, especially in the first days of
tumour development. The skeletal muscle
in the region of the tumour was exten-
sively infiltrated by tumour tissue.
Histologically (Fig. la) Sac-virus-in-
duced t,umours had a morphology similar
to that of other MSV-M tumours (Stanton
et al., 1968; Berman & Allison, 1969;
Siegler, 1970). In the first days after in-
jection of Sac virus the tissue consisted of
a loose framework of cells in which
spindle-shaped fibroblasts with vesiculated
n-Liclei '"Tere accompanied by neutrophils
in all areas. After some days the neutro-
phils grew fewer and Masson's trichrome
stain demonstrated an irregular distribu-
tion of collagen between the fibroblasts.
These cells, ofteii arranged in fascicles,
infiltrated the muscle strands, and rem-
nants of necrotic muscle fibres could be
found deep within the tumo-Lir. Electron-
microscopic examination of the tissue re-
vealed Type C virtis pai-ticles in all parts
ofthe tumour.
Later on, as the tumours begaii to
regress, lymphocytes, histiocytes (in
smaller ntimbers) and some plasma cells
coLild be demonstrated. Mostly they wei-e
seen towards the periphery of the tumour.
At this stage of tumour development,
sporadic single cell lysis was found. At the
same time some ofthe fibroblasts acquired
the typical trail of myofibroblasts (Gab-
biani et al., 1972) as demonstrated by
electron microscopy. Bundles ofintracyto-
plasmic filaments with electron-dense
areas were visible, and single junctional
complexes at the zone of contact to
adjoining cells could be seen.
After i.m. transplantation of Sac(-)
cells, well circumscribed moderately firm
tumours developed at the site of inocula-
tion, reaching diameters of about 2-0 cm
before the death of the animals. Their cut
surface was grev-white, mottled with
small yellow friable areas.
Microscopically, Sac(-) tumours coii-
sisted of sheets of neoplastic cells sup-
ported by a very small amount of con-
nective-tissue stroma (Fig. Ic, d). This
solid mass of tumour cells, sometimes
arranged in cell groups, displaced rather
than infiltrated the skeletal muscle. The
sarcoma cells were so closely approxi-
mated to one another that theirperipheral
limits were often indistinct. Mitoses could
frequently be found. Inpartsofthetumour
where the neoplastic cells were more
loosely arranged, they were round or
slightly elongated. Their cytoplasm was
homogeneous and somewhat basophilic.
The large nucleus usually contained one
prominent nucleolus (see Fig. Id).
It was very rare for infiltrating cells to
accompany theseneoplastic proliferations.
In central parts of the tumour, areas of
necrosis were often seen. At the perimeter
of such necrotic foci there was a zone of
shrunken tumour cells which were hyper-
chromatic, more isolated and some-,Nhat
smaller than the original eells. Even in
these areas, no cellular reactions were
seen. Neai- the foci of necrosis, the cells of936 F. WEILAND, E. WEILAND AND M. MUSSGAY
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FirG. l.-(a) Tumour induced by Sac virus: fibroblast tissue, remnants of muscle fibres, a cluster of
neutrophils. (b) Tumour induced by Sac(+) cells: fibroblast tissue with typical tumour cells
loosely arranged (arrows). (c, d) Tumour induced by Sac(-) cells: dense accumulation of tumour
cells. N.B. prominent nucleoli.
a, b, c Paraffin, haematoxylin and eosin. x 360.
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the sarcoma surrounding blood vessels
appeared to have survived the longest.
Electron-microscopically, tumour cells
were usually spherical. They contained a
large, round or oval nucleus with a single
prominent nucleolus and a thin layer of
chromatin near the nuclear membrane.
The prominent nucleolus was typical of
these cells. The cytoplasm contained a
small rough endoplasmic reticulum, free
ribosomes, and a single mitochondria. A
rather small Golgi zone could be demon-
strated in some sections. Type C virus
particles were not visible.
Metastases could be found in various
lymph nodes.
Morphologically variable tumours de-
veloped after inoculation of the virus-
producingSac(+) cells. A common feature
was extensive oedema surrounding the
tumour tissue, similar to that seen at the
virus-induced tumours.
Using 106 cells for transplantation,
tumours evolved which were hardly dis-
tinguishable from Sac(-) tumours. Their
solid cell growth, however, was accom-
panied by a slight inflammatory reaction
withneutrophils and, later on, fibroblasts.
These tumours always grew progressively
(Table 1).
Reduction in the number of cells inocu-
lated produced progressively and re-
gressively growing tumours at the site of
inoculation (Table 1). For example,
tumours induced by 103 cells usually
showed irregularly proliferated fibroblasts
which wereintermingled with tumour cells
with the morphological characteristics of
Sac(-) cells (Fig. lb). The neoplastic
cells, accompanied by fibroblasts, partly
surrounded by bundles of collagen fibres,
neutrophils and, later on, lymphocytes,
infiltrated surrounding tissues rather
aggressively. Tumour centres became
necrotic, and degenerating muscle fibres
could be seen in the wake oftheinfiltrating
sarcoma. Scattered Type C virus particles
could be found within the tumour tissue
by electron microscopy. In progressively
growing tumours metastases could be seen
in some lymph nodes.
Cultivation o tumourfragments
Explants from tumours were prepared
12 days after induction by virus infection
or by tumour-cell transplantation. Cul-
tures obtained from these explants
possessed different properties.
Tumour explant cultures (TEC) from
virus-induced tumours showed an out-
growth of cells consisting at first of a
mixture offusiform, round and fibroblast-
like cells. Later, morphological changes
towards purely fibroblast-like cells
occurred. Virus production changed in
parallel with these morphological altera-
tions. First, sarcoma virus in addition to
helper virus was demonstrable. After 2-3
transfers only helper virus could be de-
tected. The TEC from Sac virus-induced
tumours producing only helper virus,
were unable to induce tumours after
transplantation into adult mice.
Explants from Sac(-) or Sac(+) cell-
induced tumours led to cultures com-
parable to the original tumour-cell cul-
tures. In Table 1, lower part, the tumour
incidence fate after transplantation of
these TEC is summarized. Corresponding
with the findings shown in the upper part
of Table 1, inoculation of TEC derived
from Sac(-) cell-induced tumours always
led to progressively growino, tumours.
Inoculation of TEC from Sac(+) cell-
induced tumours, however, produced pro-
gressively orregressivelygrowingtumours,
in agreement with the original cultures.
Furthermore, the TEC from Sac(+)- or
Sac(-)-induced tumours showed the
transformed phenotype and viral proper-
ties ofthe original cultures. Colony forma-
tion in semi-solid agar was induced by
TEC derived from Sac(-)- or Sac(+)-
cell-induced tumours but not by TEC
derived from Sac-virus-induced tumours.
Immune response in mice after injection of
rescued Sac virus and Sacproducer cells
Comparison of the capacity to induce
C'-dependent cytotoxic antibodies, cyto-
toxic cells and transplantation protection
after injection of rescued Sac virus and938 F. WEILAND, E. WEILAND AND M. MUSSGAY
TABLEII.-Inductionofcytotoxic antibodiesaftertransplantationofSac(+) cells andafter
infection with Sac virus*
A-ntibody dilution
x
r- '% Tumour status 1:81 1:243 1:729 1:2187
Regressed 61§ 36 16
Small nodule 75 62 51 1411
Large (> 1-2 cmdiam.) 52 23
Inoculum
1-8 x 104t
Sac(+) cells
57 20
71 55
Sac virusl Regressed
Regressed 21
* Sac(+) cells as target cells.
t Serum collected from 3-5 mice and pooled 41 days after Sac(+)-cell transplantation.
$ Serum collected 40 days after virus injection.
§ % reduction oftarget-cell radioactivity; values are significant by the t test (P <0-01) with the exception
of II (P <0-05).
tction ofcytotoxic effector- Sacproducer cells arecompared inparallel.
iays after transplantation Table 11 shows the presence of C'-
or injection of virusfrom dependent cytotoxic antibodies after virus
injection as well as after producer-cell
Spleen-cell/target-cell ratio transplantation. The tumour stage of cell-
A induced tumours seemed to influence the
.25:1 62-5:1 31:1 antibody titres. Cytotoxic spleen cells
73t 76 77 were induced in tumour-bearers 12 days
73 75 71 after virus injection or 12 days after
transplantation of different cell doses of
69 61 37 producer cells (Table 111). Transplanta-
tion protection against challenge with
ell line Bc as target cell. Sac(+) cells could be inducedby Sac virus
target cell radioactivity are (Table IV) as well as by Sac(+) cells, as st at P < 0-001.
reported in a previous communication
ur,tinv, nf tra,,n,.qn1,a,,nh7,6,nn (Weiland etal., 1978).
TABLE III.-Indu
cell activity 12 O'
ofSac(+) cells
Sac(+) cells*
I
r--
I Inoculum
106 Sac(+)
cells
104 Sac(+)
cells
Sac virus
_L.tknjLjrJ JL V .-A IUMMULvulf, uj (a
immunity by Sac virus*
Challenge with Sac(+)
No. of
Days tumours/ Latent
Cell after No. of period
Pretreatment dose infection mice in days
Sac virus 5 X 105 12 2/6 6
5 X 104 0/6
None 5 X 105 6/6 6
5 X 104 6/6 6
Derived from Sac cells after rescue with MLV.
producer cells is summarized in Tables 11,
III and IV. In a previous paper (Weiland
et al., 1978), the immunogenic properties
ofSac(-) and Sac(+) cells were reported
in detail. It was shown that Sac(-) cells
gain the capacity to induce an immune
response only after rescue leading to virus
production. Therefore, only Sac virus and
* MLV-producing ei
t % reductions of
all significant by t te-.;
TA-RT,v, TV--[,n,d,,?
Events occurring after infection of MEF
with sarcoma virus or co-cultivationofMEF
with transformed Sac virus-producing
cells.-After infection with sarcoma virus
(Sac virus or MSV-B-62) the morph-
ology of the whole MEF-culture was
altered, starting about 60 h p.i. This state,
in which cells showed a morphology
characteristic of transformed cells, lasted
only 8-10 days. After the second weekly
transfer the cultures already resembled
the mock-infected controls. Rapp &
Todaro (1978) call this event transient
transformation.
In co-cultures of MEF with Sac(+)
cells, foci of round to fusiform cells were
observed developing on the MEF mono-
layer in the first week. Thereafter, cultures
grew out resembling more and more theTUMOURS INDUCED BY MSV OR MSV TRANSFORMED CELLS 939
Remarkable differences were seen when
the results of soft-agar assays, virus
assays, and tumour induction were com-
pared. In contrast to the co-culture that
regularly induced colonies in soft agar,
sarcoma virus-infected MEF were unable
to form colonies. The co-culture produced
sarcoma virus in addition to helper virus
over the whole observation period of 12
transfer generations. The sarcoma-virus-
infected MEF, however, released sarcoma
virus and helper virus only for 2-3 weeks;
during thefollowing 9 transfergenerations
only helper virus was demonstrable.
Tumour induction by transplantation of
sarcoma-virus-infected MEF could be ob-
served 1-2 weeks after infection, leading
to tumours which always regressed.
Tumour induction by transplantation of
co-cultured MEF and Sac(+) cells led to
tumours which showed both ultimately
progressive and regressive growth, a
behaviour characteristic of the original
transformed culture.
DlSCUSSION
Although the MSV-M system has been
studied for more than a decade thebiology
of this tumour is not yet fully understood.
It is not certain whether MSV-M injection
leads to tumour cells that are really
autonomous, i.e. whether tumourdevelop-
ment depends on the production of virus
and continuous recruitment of newly
infected transformed cell, or on the pro-
liferation of transformed cells (Levy &
Leclerc, 1977). In the avian system,
tumours are believed to grow by recruit-
ment ofnewly transformed cells by Rous-
sarcoma-virus infection (Ponte'n, 1964).
Studies with mouse tumours induced by
transplantation of stably transformed
sarcoma-virus-producing cells on the one
hand, and by injection of sarcoma virus
alone on the other, may help to answer
this question.
Recently, we reported on a non-pro-
ducer tumour cell (Sac(-)) with rescuable
sarcoma-virus genome derived from
a recurring MSV-M-induced tumour
(Weiland et al., 1978). These Sac(-) cells
Fla. 2.-Co-culture of mouse embryo fibro-
blasts (MEF) with stably transformed
Sac(+) cells.
(a) A few densely stained round cells and
spindle cells surrounded by normal cells
one week after start of the co-culture
(ratio MEF to Sac(+) cells: 20,000:1). (b) One week after the first passage the
portion ofdenselystained cellsincreases.
(c) One week after the second passage the
densely stained cells predominate
almost entirely over normal cells.
Haematoxylin and eosin. x 85.
original transformed cell culture. Fig. 2
shows 3 stages of the co-culture. Densely
stained round cells and spindle cells were
at first only sparsely seen, but finally pre-
ponderated over cells with the normal
phenotype.940 F. WEILAND, E. WEILAND AND M. MUSSGAY
are of low antigenicity and always induce
progressively growing tumours in mice. In
this respect they resemble the non-
producer cells ofAaronson & Rowe (1970).
After rescue with Moloney helper virus,
Sac(-) cells gained strong antigenicity
(Sac(+) cells) and induced a strong im-
mune response in their hosts. In spite of
this immune response, tumours with a
progressive course are able to develop.
Tumours resulting from injection of
rescued sarcoma virus(Sac-virustumours),
however, gave rise to a strong immune
response and always regressed. We were
interested to know why the antigenic
Sac(+)-cell tumour was able to grow pro-
gressively in spite of the existence of a
strong immune response and why this
never happened with Sac-virus tumours.
The following observations must be
taken into account for the interpretation
of the present results. The growth course
of Sac(+)-cell tumours is obviously de-
pendent on the number of cells used for
injection in respect of the distribution of
these cells in the tissue. If the inoculated
cells find an appropriate microenviron-
ment and are able to build up a dense
agglomeration of tumour cells, a pro-
gressively growing tumour may arise that
resists the immune defence mechanisms
which develop within a few days. This
resistance may be explained by mech-
anical prevention of immune factors from
reaching most of those densely packed
tumour cells. In this case tumour cells
prevail in the tissue and tumours develop
which are morpliologically similar to
Sac(-) tumours. They are composed of
compactly growing tumour cells accom-
panied by very little connective tissue.
Division of the implanted tumour cells
obviously predominates over new recruit-
ment of transformed cells by viral in-
fection.
Existence of immunosensitive tumour
cells in progressively growing Sac(+)-cell
tumours was recently reported (Weiland
e-t al., 1978). A tumour-cell suspension
prepared from a progressively growing
tumourwas transplanted into normal and
immune mice (pretreated with Sac virus).
Whereas the control mice developed
tumours, all immune mice remained free
of tumours, independently of the trans-
planted cell concentration.
Regression of tumours after trans-
plantation of low concentrations of
Sac(+) cells obviously occurs if virus-
induced proliferation of fibroblastic tissue
overwhelms growth of the typical tumour
cells. This produces tumours in which the
typical tumour cells are rarely visible, and
which resemble inmorphology and tumour
course Sac-virus tumours. Immune de-
struction of tumour cells may be more
successful in these tumours because they
are more loosely arranged in the tissue.
Besides the active immune response
seen in animals with Sac(+)-cell tumours
and in animals with Sac-virus-induced
tumours (Tables 11, 111, IV, and a recent
report by Weiland et al. (1978)), a peculi-
arity of the transforming capacity of
MSV_X the transient transformation
(Rapp & Todaro, 1-978) of virus infected
cells, seems to beimportant for theregular
regression of sarcoma virus-induced
tumours. In virus-induced tumours there
is no histologically characteristic type of
tumour cell. Holden et al. (1976) failed to
demonstrate tumour cells in suspensions
of MSV-M-induced tumours. We were not
successful in isolating stably transformed
cells from TEC or in inducing stably
transformed cells by sarcoma-virus infec-
tion of MEF in vitro. In Sac(+) as well as
in Sac(-) cell tumours, however, clonal
proliferation occurs. From these tumours
the cell of origin can easily be reisolated.
The cultured cells arising from Sac(+)-
and Sac(-)-cell-tumour explants re-
semble in their phenotype, growth in soft
agar and their virological and tumour
properties the cell strain used for the
tumour induction.
Interest in the regression of tumours
induced by MSV-M has almost exclusively focused on immunological events (Levy &
Leclerc, 1977), whereas the role of the
transforming capacity of MSV-M for the
tumourgrowth has been neglected. To ourTUMOURS INDUCED BY MSV OR MSV TRANSFORMED CELLS 941
knowledge, the only exception is a report
by Penelli et al. (1975), in which the
peculiar behaviour of MSV-M-infected
cells is discussed as a reason for the
regular regression of MSV-M-induced
tumours, besides the existence of an im-
mune response in tumour-bearing hosts.
In thisrespect, itisinteresting to note that
Simons & McCully (MO) were not suc-
cessful in establishing transplantable
tumours after MSV-M infection, and that
Simons (1970) did not succeed in inducing
stably MSV-M-transformed mouse fibro-
blasts in vitro. According to Gazdar et al.
(1976), most acutely MSV-M-infected
mouse cells fail to divide, although many
of them retain the ability to exclude
Trypan blue.
Parkman et al. (1970) supposed that
overgrowth of MSV-M-transformed MEF
by helper-virus-infected MEF was the
reason for the failure to establish MSV-M-
transformed mouse cells, since MLV-M is
usually found in excess in MSV stocks
(Hartley & Rowe, 1966). However, the
results of our co-culture studies with MEF
and few Sac(+) cells do not support this
assumption. The transformed Sac(+) cells
overgrew MEF after 3 transfers at weekly
intervals. Repetition of this experiment
with MLV-M-infected MEF showed the
same results (data not shown).
In special cases stable transformation
of mouse cellsby MSV-M can be achieved.
By the use of particular cell strains such
as BALB/3T3 and NIH/3T3 (Jainchill et
al., 1969), or by the use ofparticular virus
strains such as the widely used S +L
strain (Bassin et al., 1970; Aaronson et al.,
1972; Peebles et al., 1975), that contains
MSV-M in a greater amount than MLV-M.
Though it is possible experimentally to
obtain stably MSV-M-transformed mouse
cells, it seems to be a rare event (Bassin
et al., 1970). The ratio of MSV-M-induced
foci to soft-agar-colony-forming units was
in excess of 1000 to 1, compared to a ratio
of 50 to I obtained with the B-34 virus
derived from MSV-Harvey-induced ham-
ster tumour cells (Zavada & Macpherson,
1970).
The motive for our studies was the
question: why do two tumours which
induce the same immune response in their
hosts differ in the -course they run? The
data reported here suggest that the fate of
a tumour is not only dependent on its in-
duced immune response but also on its
growth properties. An MSV-M tumour
regularly shows regression due to the
strong immune response it induces and
the fact that MSV-M infection onlyrarely,
if at all, results in autonomous tumour
cells. However, a tumour induced by
transplantation ofvirus-producing (there-
fore strongly antigenic) autonomous cells
is able to grow progressively in the pre-
sence of a strong immune response. This is
assumed to be due to the mode ofgrowth
preventing intimate contact between the
transplanted cells with immune defence
mechanisms.
We are indebted to Dr J. H. Cox for reading the
manuscript. We wish to thank Miss A. Schenk and
Alr G. Balke for tecbnical assistance.
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